Sun Pharmaceutical Industries Limited reported earnings results for the second quarter and six months ended September 30, 2025. For the second quarter, the company reported sales was INR 144,052.2 million compared to INR 132,642.2 million a year ago. Revenue was INR 149,482.3 million compared to INR 136,453.9 million a year ago. Net income was INR 31,179.5 million compared to INR 30,401.6 million a year ago. Basic earnings per share from continuing operations was INR 13 compared to INR 12.7 a year ago. Diluted earnings per share from continuing operations was INR 13 compared to INR 12.7 a year ago.
For the six months, sales was INR 281,912.9 million compared to INR 257,887.3 million a year ago. Revenue was INR 292,640.9 million compared to INR 268,306.9 million a year ago. Net income was INR 53,965.8 million compared to INR 58,757.8 million a year ago. Basic earnings per share from continuing operations was INR 22.5 compared to INR 24.5 a year ago. Diluted earnings per share from continuing operations was INR 22.5 compared to INR 24.5 a year ago.